{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:24:24Z","timestamp":1793381064905,"version":"4.5.0"},"reference-count":46,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Although low-density-lipoprotein cholesterol (LDL-C) remains the primary target of lipid-lowering therapy, many patients with atherosclerotic cardiovascular disease (ASCVD) continue to experience cardiovascular events. This residual risk suggests that LDL-C alone does not fully capture the total atherogenic burden. Alternative lipid measures, including non-high-density lipoprotein cholesterol (non-HDL-C) and cholesterol ratios, may provide a more comprehensive risk assessment, particularly in populations with a high prevalence of metabolic disorders. This study assessed the prevalence and clinical determinants of elevated non-HDL cholesterol and adverse cholesterol ratios among Middle Eastern patients with established ASCVD. Methods: This pooled cross-sectional analysis included 2763 adults with confirmed ASCVD from the Jordan SMuRF-less Study and six cardiovascular registries across the Middle East. Patients were stratified by standard modifiable cardiovascular risk factors (SMuRFs). Demographic, clinical, treatment, and lifestyle data were harmonized and analyzed using multivariable regression models. Results: Elevated non-HDL-C was observed in 54% of patients. Those with elevated non-HDL-C were younger (55.0 vs. 59.9 years) and more frequently current smokers (52.6% vs. 43.1%). Hypertension (64.2% vs. 51.0%) and heart failure (25.0% vs. 15.4%) were more common among patients with lower non-HDL-C, whereas dyslipidemia (90.8% vs. 75.8%) and acute coronary syndrome (88.1% vs. 83.7%) were more prevalent in the elevated group. Elevated non-HDL-C was associated with higher baseline LDL-C levels measured prior to the initiation of lipid-lowering therapy (141.3 vs. 81.1 mg\/dL) and higher triglycerides (221.4 vs. 140.9 mg\/dL). In multivariable analyses, age &gt; 60 years (OR = 0.45), hypertension (OR = 0.74), and heart failure (OR = 0.61) were inversely associated with elevated non-HDL-C. Conclusions: Elevated non-HDL cholesterol is common among Middle Eastern patients with ASCVD, particularly younger individuals, reflecting early metabolic risk and increased atherogenic burden. Non-HDL-C is a valuable marker of residual cardiovascular risk, supporting earlier screening and region-specific prevention strategies.<\/jats:p>","DOI":"10.3390\/healthcare14050565","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:42:22Z","timestamp":1772012542000},"page":"565","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-HDL Cholesterol and Residual Cardiometabolic Risk in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3268-2259","authenticated-orcid":false,"given":"Osama","family":"Alkouri","sequence":"first","affiliation":[{"name":"Faculty of Nursing, Yarmouk University, P.O. Box 566, Irbid 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1050-1680","authenticated-orcid":false,"given":"Ahmad M.","family":"Al-Bashaireh","sequence":"additional","affiliation":[{"name":"Faculty of Nursing, Philadelphia University, Jarash Road, Amman 19392, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanoud","family":"Alobaidly","sequence":"additional","affiliation":[{"name":"College of Nursing and Health Sciences, Flinders University, Bedford Park, SA 5042, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4823-0731","authenticated-orcid":false,"given":"Ghaleb","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, College of Pharmacy, Shaqra University, Shaqra 11961, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6008-6908","authenticated-orcid":false,"given":"Rahma Musaed","family":"Alabkal","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ministry of Health, Kuwait City 13001, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6712-5797","authenticated-orcid":false,"given":"Abdullah","family":"Hasan","sequence":"additional","affiliation":[{"name":"College of Nursing, The Public Authority for Applied Education and Training, Shuwaikh, Kuwait City 72853, Kuwait"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayman","family":"Hammoudeh","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Istishari Hospital, Amman 11184, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4514-6755","authenticated-orcid":false,"given":"Nisreen","family":"Nusair","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Miami University, Oxford, OH 45056, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolly","family":"Isaac","sequence":"additional","affiliation":[{"name":"Hind Bint Maktoum College of Nursing and Midwifery, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai Health Care City, Dubai 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkareem","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Advanced Diagnostic and Therapeutic Institute, King Abdulaziz City for Science and Technology (KACST), Riyadh 12354, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-4445","authenticated-orcid":false,"given":"Ahmad Rajeh","family":"Saifan","sequence":"additional","affiliation":[{"name":"Faculty of Nursing, Yarmouk University, P.O. Box 566, Irbid 21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6947-2642","authenticated-orcid":false,"given":"Nezam","family":"Al-Nsair","sequence":"additional","affiliation":[{"name":"Hind Bint Maktoum College of Nursing and Midwifery, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai Health Care City, Dubai 505055, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5334\/gh.1341","article-title":"Atherosclerotic cardiovascular disease novel and traditional risk factors in Middle Eastern young women. The ANCORS-YW study","volume":"19","author":"Hammoudeh","year":"2024","journal-title":"Glob. Heart"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1605502","DOI":"10.3389\/ijph.2023.1605502","article-title":"Global epidemiological patterns in the burden of main non-communicable diseases, 1990\u20132019: Relationships with socio-demographic index","volume":"68","author":"Bai","year":"2023","journal-title":"Int. J. Public Health"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Stanciulescu, L.A., Scafa-Udriste, A., and Dorobantu, M. (2023). Exploring the association between low-density lipoprotein subfractions and major adverse cardiovascular outcomes\u2014A comprehensive review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24076669"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"101819","DOI":"10.1016\/j.pmedr.2022.101819","article-title":"Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices","volume":"27","author":"Thongtang","year":"2022","journal-title":"Prev. Med. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e148559","DOI":"10.1172\/JCI148559","article-title":"Addressing dyslipidemic risk beyond LDL-cholesterol","volume":"132","author":"Tall","year":"2022","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"117312","DOI":"10.1016\/j.atherosclerosis.2023.117312","article-title":"Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook","volume":"383","author":"Raja","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"723","DOI":"10.36347\/sjams.2022.v10i05.008","article-title":"Changing Recommendations on the Use of Non-Fasting Versus a Fasting Lipid Profile: A Review of Current Literature","volume":"5","author":"Bery","year":"2022","journal-title":"Sch. J. Appl. Med. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"C2","DOI":"10.1093\/eurheartj\/suw009","article-title":"Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia","volume":"18","author":"Ferrari","year":"2016","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kosmas, C.E., Rodriguez Polanco, S., Bousvarou, M.D., Papakonstantinou, E.J., Pe\u00f1a Genao, E., Guzman, E., and Kostara, C.E. (2023). The triglyceride\/high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a risk marker for metabolic syndrome and cardiovascular disease. Diagnostics, 13.","DOI":"10.3390\/diagnostics13050929"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Calling, S., Johansson, S.-E., Wolff, M., Sundquist, J., and Sundquist, K. (2019). The ratio of total cholesterol to high density lipoprotein cholesterol and myocardial infarction in Women\u2019s health in the Lund area (WHILA): A 17-year follow-up cohort study. BMC Cardiovasc. Disord., 19.","DOI":"10.1186\/s12872-019-1228-7"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/00015385.2020.1742455","article-title":"Lipid and cardiometabolic features of T2DM patients achieving stricter LDL-C and non-HDL-C targets in accordance with ESC\/EAS 2019 guidelines","volume":"76","author":"Hermans","year":"2021","journal-title":"Acta Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: A report of the American College of Cardiology Solution Set Oversight Committee","volume":"80","author":"Committee","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4239\/wjd.v12.i9.1401","article-title":"Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action","volume":"12","author":"Bidikian","year":"2021","journal-title":"World J. Diabetes"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41371-021-00554-z","article-title":"Hypertension in the Middle East: Current state, human factors, and barriers to control","volume":"36","author":"Abboud","year":"2022","journal-title":"J. Hum. Hypertens."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1038\/s41598-022-06418-x","article-title":"The burden of stroke and its attributable risk factors in the Middle East and North Africa region, 1990\u20132019","volume":"12","author":"Jaberinezhad","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1995-705X.206206","article-title":"Outcomes of middle eastern patients undergoing percutaneous coronary intervention: The primary analysis of the first Jordanian PCI registry","volume":"18","author":"Alhaddad","year":"2017","journal-title":"Heart Views"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Alkouri, O., Albikawi, Z., Saifan, A.R., Khatatbeh, H., Ababneh, A., Alobaidly, A., Qaladi, O., Alharbi, A., Hasan, A., and Jarrah, M. (2025). Stratifying atherosclerotic cardiovascular disease by SMuRF burden in a Middle-Eastern country: A multiregistry study of demographics, comorbidities, and therapeutic trends. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0332302"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/VHRM.S499355","article-title":"Absence of Standard Modifiable Risk Factors in Middle Eastern Patients with Atherosclerotic Cardiovascular Disease. The Jordan Absence of Standard Modifiable Risk Factors (SMuRF-Less) Study","volume":"21","author":"Hammoudeh","year":"2025","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e027851","DOI":"10.1161\/JAHA.122.027851","article-title":"Mortality in patients hospitalized with acute myocardial infarction without standard modifiable risk factors: The ARIC study community surveillance","volume":"12","author":"Chunawala","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e013296","DOI":"10.1161\/JAHA.119.013296","article-title":"ST-segment\u2013elevation myocardial infarction (STEMI) patients without standard modifiable cardiovascular risk factors\u2014How common are they, and what are their outcomes?","volume":"8","author":"Vernon","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jacl.2024.09.005","article-title":"Managing hypercholesterolemia in adults older than 75 years without a history of atherosclerotic cardiovascular disease: An Expert Clinical Consensus from the National Lipid Association and the American Geriatrics Society","volume":"19","author":"Bittner","year":"2025","journal-title":"J. Clin. Lipidol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: A meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","author":"Armitage","year":"2019","journal-title":"Lancet"},{"key":"ref_27","unstructured":"Padda, I.S., Fabian, D., and Johal, G.S. (2026, February 13). Familial Combined Hyperlipidemia. Available online: https:\/\/europepmc.org\/article\/NBK\/nbk592399."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11883-014-0482-5","article-title":"Familial hypercholesterolemia\u2014Epidemiology, diagnosis, and screening","volume":"17","author":"Singh","year":"2015","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.atherosclerosis.2018.10.022","article-title":"Spectrum of mutations of familial hypercholesterolemia in the 22 Arab countries","volume":"279","author":"Alhababi","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1849454418779310","DOI":"10.1177\/1849454418779310","article-title":"Associations between smoking and lipid\/lipoprotein concentrations among US adults aged \u2265 20 years","volume":"7","author":"Jain","year":"2018","journal-title":"J. Circ. Biomark."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12933-016-0475-5","article-title":"Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: A systematic review and meta-analysis","volume":"15","author":"Kar","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_32","first-page":"26","article-title":"Cigarette Smoking and its Association with Dyslipidemia among Middle-aged Population in Rajshahi District","volume":"13","author":"Yasmin","year":"2023","journal-title":"Ibrahim Card. Med. J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"942","DOI":"10.5551\/jat.56838","article-title":"Relationships between smoking status, cardiovascular risk factors, and lipoproteins in a large Japanese population","volume":"28","author":"Nakamura","year":"2021","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1001\/jama.2012.366","article-title":"Association of LDL cholesterol, non\u2013HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: A meta-analysis","volume":"307","author":"Boekholdt","year":"2012","journal-title":"JAMA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/MOL.0000000000000875","article-title":"Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease","volume":"34","author":"Ganda","year":"2023","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: New insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ. Res."},{"key":"ref_37","unstructured":"Yang, X., Li, K., Xu, G., Wen, J., Xiao, H., Chen, L., Yang, C., Chen, Y., Liu, Y., and Zhao, Y. (2016, February 13). Association Between Non-High-Density Lipoprotein Cholesterol and Coronary Artery Disease in Patients with Acute Coronary Syndrome: A Single-Centre Retrospective Cross-Sectional Analysis. Available online: https:\/\/www.researchsquare.com\/article\/rs-4905958\/v1."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s11883-024-01225-3","article-title":"Cardiovascular risk estimation and stratification among individuals with hypercholesterolemia","volume":"26","author":"Bosco","year":"2024","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jacc.2019.03.010","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/CRD.0000000000000417","article-title":"Exercise, physical activity, and cardiometabolic health: Pathophysiologic insights","volume":"30","author":"Belanger","year":"2022","journal-title":"Cardiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Franczyk, B., Gluba-Brz\u00f3zka, A., Cia\u0142kowska-Rysz, A., \u0141awi\u0144ski, J., and Rysz, J. (2023). The impact of aerobic exercise on HDL quantity and quality: A narrative review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054653"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13098-023-01017-w","article-title":"Insulin resistance, lipids and body composition in patients with coronary artery disease after combined aerobic training and resistance training: A randomised, controlled trial","volume":"15","author":"Kambic","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"102870","DOI":"10.1016\/j.dsx.2023.102870","article-title":"Prevalence of dyslipidemias in the Middle East region: A systematic review & meta-analysis study","volume":"17","author":"Kargar","year":"2023","journal-title":"Diabetes Metab. Syndr. Clin. Res. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e061350","DOI":"10.1136\/bmjopen-2022-061350","article-title":"Global, regional and national trends in statin utilisation in high-income and low\/middle-income countries, 2015\u20132020","volume":"12","author":"Guadamuz","year":"2022","journal-title":"BMJ Open"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Xia, Q., Chen, Y., Yu, Z., Huang, Z., Yang, Y., Mao, A., and Qiu, W. (2023). Prevalence, awareness, treatment, and control of dyslipidemia in Chinese adults: A systematic review and meta-analysis. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1186330"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Alhabib, K.F., Al-Rasadi, K., Almigbal, T.H., Batais, M.A., Al-Zakwani, I., Al-Allaf, F.A., Al-Waili, K., Zadjali, F., Alghamdi, M., and Alnouri, F. (2021). Familial hypercholesterolemia in the Arabian Gulf region: Clinical results of the gulf fh registry. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0251560"}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/5\/565\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T10:14:22Z","timestamp":1772014462000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/14\/5\/565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["healthcare14050565"],"URL":"https:\/\/doi.org\/10.3390\/healthcare14050565","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]}}}